ConductScience.org, home

Paper19276366

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

Santisteban M and 12 others. Cancer Res, 2009. Cited by 327 papers, by iCite.

Cite this record

ConductScience Library. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Papers, record 19276366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19276366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
PubMed
Journal
Cancer Res
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
327
iCite
Relative citation ratio, by iCite
6.82
iCite
Revised in PubMed
2025-05-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Santisteban MMarta
2Reiman JMJennifer M
3Asiedu MKMichael K
4Behrens MDMarshall D
5Nassar AAziza
6Kalli KRKimberly R
7Haluska PPaul
8Ingle JNJames N
9Hartmann LCLynn C
10Manjili MHMasoud H
11Radisky DCDerek C
12Ferrone SSoldano
13Knutson KLKeith L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mammary Neoplasms, ExperimentalMajor topic
Neoplastic Stem CellsMajor topic
Animals
CD24 Antigen
CD8-Positive T-Lymphocytes
DNA Repair Enzymes
Epithelial Cells
Female
Gene Expression
Genes, erbB-2
Hyaluronan Receptors
Mesoderm
Mice
Mice, Transgenic
Mitoxantrone

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50-CA116201NCI NIH HHSUnited StatesP50CA116201PubMed and NIHNIH RePORTER
P50 CA116201NCI NIH HHSUnited StatesP50CA116201PubMed and NIHNIH RePORTER
K01 CA100764NCI NIH HHSUnited StatesK01CA100764PubMed and NIHNIH RePORTER
K01-CA100764NCI NIH HHSUnited StatesK01CA100764PubMed and NIHNIH RePORTER
R01 CA113861NCI NIH HHSUnited StatesR01CA113861PubMed and NIHNIH RePORTER
R01-CA113861NCI NIH HHSUnited StatesR01CA113861PubMed and NIHNIH RePORTER
R01 CA138188NCI NIH HHSUnited StatesR01CA138188PubMed and NIHNIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112427868EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties.J Cell Biol2002https://conductscience.org/library/papers/12427868PubMed
218485877The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell2008https://conductscience.org/library/papers/18485877PubMed
310086791A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population.Br J Haematol1999https://conductscience.org/library/papers/10086791PubMed
417975224Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.Stem Cells2008https://conductscience.org/library/papers/17975224PubMed
512629218Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12629218PubMed
617851725Isolation murine mesenchymal stem cells by positive selection.In Vitro Cell Dev Biol Anim2007https://conductscience.org/library/papers/17851725PubMed
716360718Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it.Semin Oncol2005https://conductscience.org/library/papers/16360718PubMed
818381452Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.Cancer Res2008https://conductscience.org/library/papers/18381452PubMed
915989948Complicated tails: histone modifications and the DNA damage response.Cell2005https://conductscience.org/library/papers/15989948PubMed
1014595126The profile of gene expression of human marrow mesenchymal stem cells.Stem Cells2003https://conductscience.org/library/papers/14595126PubMed
1116428468Targeted modulation of MGMT: clinical implications.Clin Cancer Res2006https://conductscience.org/library/papers/16428468PubMed
1216397499Generation of a functional mammary gland from a single stem cell.Nature2006https://conductscience.org/library/papers/16397499PubMed
1317229949The prognostic role of a gene signature from tumorigenic breast-cancer cells.N Engl J Med2007https://conductscience.org/library/papers/17229949PubMed
1416169465The transcriptional repressor Snail promotes mammary tumor recurrence.Cancer Cell2005https://conductscience.org/library/papers/16169465PubMed
1517998939Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice.Oncogene2008https://conductscience.org/library/papers/17998939PubMed
1618349857Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?Nat Clin Pract Oncol2008https://conductscience.org/library/papers/18349857PubMed
1718266270Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.Eur J Immunol2008https://conductscience.org/library/papers/18266270PubMed
1816211331Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals".Breast Cancer Res Treat2006https://conductscience.org/library/papers/16211331PubMed
1917179479The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.J Natl Cancer Inst2006https://conductscience.org/library/papers/17179479PubMed
2015803154Tumour stem cells and drug resistance.Nat Rev Cancer2005https://conductscience.org/library/papers/15803154PubMed

See all 40 referencesDownload CSV of references

Cited by232

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.

PMIDTitleJournalYearIn PapersSource
42613325Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42613325PubMed
41211430Role of EMT in drug resistance of breast cancer: molecular mechanisms and therapeutic strategies.Front Oncol2025https://conductscience.org/library/papers/41211430PubMed
40663561Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression.PLoS Biol2025https://conductscience.org/library/papers/40663561PubMed
40003637Notch and Hedgehog Signaling Unveiled: Crosstalk, Roles, and Breakthroughs in Cancer Stem Cell Research.Life (Basel)2025https://conductscience.org/library/papers/40003637PubMed
39635838Role of vascular endothelium and exosomes in cancer progression and therapy (Review).Int J Oncol2025https://conductscience.org/library/papers/39635838PubMed
39529126SpottedPy quantifies relationships between spatial transcriptomic hotspots and uncovers environmental cues of epithelial-mesenchymal plasticity in breast cancer.Genome Biol2024https://conductscience.org/library/papers/39529126PubMed
38692097Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence.Mol Immunol2024https://conductscience.org/library/papers/38692097PubMed
38594465Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.Cancer Gene Ther2024https://conductscience.org/library/papers/38594465PubMed
38303523Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.Curr Stem Cell Res Ther2025https://conductscience.org/library/papers/38303523PubMed
38251077NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.Technol Health Care2024https://conductscience.org/library/papers/38251077PubMed
38244071The role of stromal cells in epithelial-mesenchymal plasticity and its therapeutic potential.Discov Oncol2024https://conductscience.org/library/papers/38244071PubMed
38243040Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma.Sci Rep2024https://conductscience.org/library/papers/38243040PubMed
37386520Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms.Cell Biosci2023https://conductscience.org/library/papers/37386520PubMed
36717668Mechanisms driving the immunoregulatory function of cancer cells.Nat Rev Cancer2023https://conductscience.org/library/papers/36717668PubMed
36521737Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.Semin Cancer Biol2023https://conductscience.org/library/papers/36521737PubMed
36291900Resistance to Trastuzumab.Cancers (Basel)2022https://conductscience.org/library/papers/36291900PubMed
36090045
Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response.
Front Mol Biosci2022https://conductscience.org/library/papers/36090045PubMed
35845599Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35845599PubMed
35735628Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers.Curr Issues Mol Biol2022https://conductscience.org/library/papers/35735628PubMed
35392236Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.Front Oncol2022https://conductscience.org/library/papers/35392236PubMed

See all 232 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
ATXN16310PubTator's text mininghttps://conductscience.org/library/genes/6310NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CD24100133941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CLDN31365PubTator's text mininghttps://conductscience.org/library/genes/1365NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FAM3C10447PubTator's text mininghttps://conductscience.org/library/genes/10447NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255NCBI Gene
MRE114361PubTator's text mininghttps://conductscience.org/library/genes/4361NCBI Gene
PRKDC5591PubTator's text mininghttps://conductscience.org/library/genes/5591NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
RAD525893PubTator's text mininghttps://conductscience.org/library/genes/5893NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19276366

GET https://conductscience.org/api/papers/v1/19276366/references?page=2